Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) FCF Margin (2016 - 2025)

Firefly Neuroscience has reported FCF Margin over the past 15 years, most recently at 443.69% for Q4 2025.

  • Quarterly results put FCF Margin at 443.69% for Q4 2025, up 200537.0% from a year ago — trailing twelve months through Dec 2025 was 728.72% (up 510739.0% YoY), and the annual figure for FY2025 was 728.72%, up 510739.0%.
  • FCF Margin for Q4 2025 was 443.69% at Firefly Neuroscience, down from 405.67% in the prior quarter.
  • Over the last five years, FCF Margin for AIFF hit a ceiling of 2137.11% in Q3 2023 and a floor of 11630.0% in Q2 2024.
  • Median FCF Margin over the past 5 years was 81.68% (2023), compared with a mean of 2021.54%.
  • Biggest five-year swings in FCF Margin: crashed -1161078bps in 2024 and later surged 1082666bps in 2025.
  • Firefly Neuroscience's FCF Margin stood at 7.98% in 2021, then plummeted by -1735bps to 146.47% in 2022, then soared by 173bps to 106.47% in 2023, then tumbled by -2400bps to 2449.06% in 2024, then soared by 82bps to 443.69% in 2025.
  • The last three reported values for FCF Margin were 443.69% (Q4 2025), 405.67% (Q3 2025), and 803.34% (Q2 2025) per Business Quant data.